JP2024008479A - Drink and lotion - Google Patents
Drink and lotion Download PDFInfo
- Publication number
- JP2024008479A JP2024008479A JP2022110392A JP2022110392A JP2024008479A JP 2024008479 A JP2024008479 A JP 2024008479A JP 2022110392 A JP2022110392 A JP 2022110392A JP 2022110392 A JP2022110392 A JP 2022110392A JP 2024008479 A JP2024008479 A JP 2024008479A
- Authority
- JP
- Japan
- Prior art keywords
- cbd
- cannabidiol
- drink
- lotion
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 16
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims abstract description 35
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims abstract description 35
- 229950011318 cannabidiol Drugs 0.000 claims abstract description 35
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims abstract description 35
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims abstract description 32
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 241000209094 Oryza Species 0.000 claims abstract description 9
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 235000009566 rice Nutrition 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 abstract description 6
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 abstract description 6
- 229960004242 dronabinol Drugs 0.000 abstract description 6
- 230000003796 beauty Effects 0.000 abstract description 3
- 238000000855 fermentation Methods 0.000 abstract description 3
- 230000004151 fermentation Effects 0.000 abstract description 3
- 241000207199 Citrus Species 0.000 abstract 1
- 235000008575 Pinus pinea Nutrition 0.000 abstract 1
- 240000007789 Pinus pinea Species 0.000 abstract 1
- 235000020971 citrus fruits Nutrition 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 description 11
- 235000013361 beverage Nutrition 0.000 description 7
- 229930003827 cannabinoid Natural products 0.000 description 3
- 239000003557 cannabinoid Substances 0.000 description 3
- ZROLHBHDLIHEMS-HUUCEWRRSA-N (6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCC)=CC(O)=C3[C@@H]21 ZROLHBHDLIHEMS-HUUCEWRRSA-N 0.000 description 2
- ZROLHBHDLIHEMS-UHFFFAOYSA-N Delta9 tetrahydrocannabivarin Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCC)=CC(O)=C3C21 ZROLHBHDLIHEMS-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- REOZWEGFPHTFEI-JKSUJKDBSA-N Cannabidivarin Chemical compound OC1=CC(CCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 REOZWEGFPHTFEI-JKSUJKDBSA-N 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical group CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
Images
Abstract
Description
本発明は、飲み物及び化粧水に関する。 The present invention relates to drinks and lotions.
例えば、特許文献1には、テトラヒドロカンナビノール(THC)、カンナビジオール(CBD)、カンナビジバリン(CBDV)、テトラヒドロカンナビバリン(THCV)から選択される1種のカンナビノイド化合物又はその医薬的に許容される塩の、神経皮膚炎を治療するための医薬組成物の単独製造における用途が開示されている。
For example,
また、特許文献2には、カンナビジオール(CBD);カンナビゲロール(CBG)である、第1の微量カンナビノイド;少なくとも第1の選択されたテルペン;及び、場合により、少なくとも第2の微量カンナビノイドを含む薬学的活性成分が開示されている。
健康又は美容に良い飲み物又は化粧水を提供することを目的とする。 The purpose is to provide drinks or lotions that are good for health or beauty.
本発明に係る飲み物は、カンナビジオールと、塩と、コメ発酵液とを含む。 The drink according to the present invention contains cannabidiol, salt, and fermented rice liquid.
また、本発明に係る化粧水は、カンナビジオールと、塩と、コメ発酵液と、高野槇又は橘の抽出物とを含む。 Further, the lotion according to the present invention contains cannabidiol, salt, fermented rice liquid, and extract of Koya Maki or Tachibana.
健康又は美容に良い飲み物又は化粧水を提供することができる。 Drinks or lotions good for health or beauty can be provided.
本発明の第1の実施形態を説明する。
本実施形態のCBD飲料は、カンナビジオールと、塩と、コメ発酵液とが含まれた飲み物である。
CBD飲料に含まれるカンナビジオールは、大麻の抽出物であり、例えば、テトラヒドロカンナビノール(THC)が完全に除去されたカンナビジオール抽出液である。カンナビジオール抽出液は、水2000mlに対して、4ml~20ml配合される。
CBD飲料に含まれる塩は、精製塩であってもよいし、海塩等の自然塩であってもよい。塩は、水2000mlに対して、6g~14g配合される。
CBD飲料に含まれるコメ発酵液は、例えば、清酒である。清酒は、水2000mlに対して、10ml~20ml配合される。
さらに、本例のCBD飲料には、ハチミツが適量含まれている。
A first embodiment of the present invention will be described.
The CBD drink of this embodiment is a drink containing cannabidiol, salt, and fermented rice liquid.
The cannabidiol contained in a CBD beverage is an extract of cannabis, for example, a cannabidiol extract from which tetrahydrocannabinol (THC) has been completely removed. 4 to 20 ml of cannabidiol extract is added to 2000 ml of water.
The salt contained in the CBD beverage may be purified salt or natural salt such as sea salt. 6g to 14g of salt is added to 2000ml of water.
The rice fermentation liquid contained in the CBD beverage is, for example, sake. 10 to 20 ml of sake is added to 2000 ml of water.
Furthermore, the CBD beverage of this example contains an appropriate amount of honey.
本例のCBD飲料は、水2000mlに対して、カンナビジオール抽出液8ml~12mlと、食塩8g~10gと、清酒14ml~16mlと、ハチミツ80g~100gとを投入して、よくかき混ぜることにより製造される。 The CBD beverage of this example is produced by adding 8 ml to 12 ml of cannabidiol extract, 8 g to 10 g of salt, 14 ml to 16 ml of sake, and 80 g to 100 g of honey to 2000 ml of water and stirring well. Ru.
次に、第2の実施形態を説明する。
本実施形態のCBD化粧水は、カンナビジオールと、塩と、コメ発酵液と、高野槇又は橘の抽出物とが含まれた化粧水である。すなわち、本例のCBD化粧水は、上記CBD飲料に、高野槇又は橘の抽出物を添加したものである。
高野槇又は橘の抽出物の添加量は、CBD飲料100mlに対して、2滴又は3滴である。
さらに、CBD化粧水には、ベンチレングリコールやグリセリン等が添加されてもよい。
Next, a second embodiment will be described.
The CBD lotion of this embodiment is a lotion containing cannabidiol, salt, fermented rice liquid, and extract of Koya Maki or Tachibana. That is, the CBD lotion of this example is obtained by adding Koya Maki or Tachibana extract to the above-mentioned CBD beverage.
The amount of Koya Maki or Tachibana extract added is 2 or 3 drops per 100 ml of CBD beverage.
Furthermore, benchlene glycol, glycerin, etc. may be added to the CBD lotion.
図1は、CBD化粧水の効果を示す図である。
40名の被験者について、CBD化粧水の使用前後におけるスキンチェッカーによる肌状態の測定と、CBD化粧水の使用前後における首の前後運動の角度の測定を行った。図1の値は、その一部である。
スキンチェッカーによる肌変化の平均は、水分量(SMC)が36.9増加し、弾性(SE)は15.16増加し、油分量(SOC)は13.38減少し、肌年齢は8歳若返った。
首の前後運動の角度は、平均で16.61度より大きく曲げられるようになった。
これらのデータからわかるのは、本例のCBD化粧水によって皮膚の弾力を取り戻し、収縮性の柔軟度が向上していることがわかる。
FIG. 1 is a diagram showing the effect of CBD lotion.
For 40 subjects, the skin condition was measured using a skin checker before and after using the CBD lotion, and the angle of back and forth neck movement was measured before and after using the CBD lotion. The values shown in FIG. 1 are a part of it.
The average skin changes determined by Skin Checker were: water content (SMC) increased by 36.9, elasticity (SE) increased by 15.16, oil content (SOC) decreased by 13.38, and skin age became 8 years younger.
The angle of forward and backward movement of the neck was now greater than 16.61 degrees on average.
These data show that the CBD lotion of this example restores skin elasticity and improves contractile flexibility.
Claims (2)
塩と、
コメ発酵液と
を含む飲み物。 Cannabidiol and
salt and
A drink containing fermented rice liquid.
塩と、
コメ発酵液と、
高野槇又は橘の抽出物と
を含む化粧水。 Cannabidiol and
salt and
rice fermented liquid,
A lotion containing an extract of Koya Maki or Tachibana.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022110392A JP2024008479A (en) | 2022-07-08 | 2022-07-08 | Drink and lotion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022110392A JP2024008479A (en) | 2022-07-08 | 2022-07-08 | Drink and lotion |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2024008479A true JP2024008479A (en) | 2024-01-19 |
Family
ID=89544778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022110392A Pending JP2024008479A (en) | 2022-07-08 | 2022-07-08 | Drink and lotion |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2024008479A (en) |
-
2022
- 2022-07-08 JP JP2022110392A patent/JP2024008479A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Arenas‐Jal et al. | Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges | |
Terauchi et al. | Effects of grape seed proanthocyanidin extract on menopausal symptoms, body composition, and cardiovascular parameters in middle-aged women: a randomized, double-blind, placebo-controlled pilot study | |
WO2019155337A1 (en) | Compositions comprising a cannabinoid and punicalagin and methods of use thereof | |
CN108697685A (en) | Containing moracin, Phellinus copper G or the root bark of white mulberry, the prevention of muscle disease and treatment is used or muscular function improvement composition | |
Shah et al. | A systematic review of effects of vitamin E on the cardiovascular system | |
TW201834648A (en) | Lipid metabolism-promoting composition including isoxanthohumol | |
Farhan et al. | The pharmacological properties of red grape polyphenol resveratrol: clinical trials and obstacles in drug development | |
Mardon et al. | Influence of lifelong soy isoflavones consumption on bone mass in the rat | |
JP2024008479A (en) | Drink and lotion | |
US20190223486A1 (en) | Catechin absorption enhancer for enhancing catechin absorption in small intestinal epithelial cells | |
Cheung et al. | Lipid-lowering nutraceuticals for an integrative approach to dyslipidemia | |
JP2006298887A (en) | Active oxygen-removing agent, skin elasticity-retaining agent, anti-oxidizing action auxiliary | |
WO2020031961A1 (en) | Composition for promoting uric acid excretion, composition for inhibiting urat1 and composition for lowering blood uric acid level | |
JP2003334022A (en) | Endurance-improving food composition | |
Parnham et al. | Mild plant and dietary immunomodulators | |
US11864570B2 (en) | Therapeutic composition including carbonated solution | |
JP2006321784A (en) | Alpha-lipoic acid water solution and its manufacturing method | |
Strohmaier et al. | Reduction of high-energy shock-wave-induced renal tubular injury by selenium | |
JP2006131610A (en) | Agent for suppressing increase of alcohol metabolite concentration | |
JP7015308B2 (en) | Catechin absorption enhancer in small intestinal epithelial cells | |
JP2021070639A (en) | Composition | |
JP5359527B2 (en) | Beverage | |
JP2006316039A (en) | Complex with enhanced stability and biological utilization rate and method for production thereof | |
TW202027724A (en) | Use of extract of victoria cruziana for inducing expression of keratin gene and hyaluronan synthase 2 gene, and enhancing moisture-retaining capacity of skin | |
JP6260538B2 (en) | Oral liquid composition |